A comparative clinical study to evaluate the efficacy of Sthaulyapakarshaniya kwatha and Lekhana basti in Sthaulya (Obesity)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Mild improvement - 1 to 33% relief
研究概览
简要总结
Thereare various treatment modalities for sthaulya.Both the shodhana therapies and shamana therapies are mentioned for sthaulya. Since, the pathogenesis of sthaulya is due to the vitiation of ‘agni’, ‘vata’ and ‘meda’,thetreatment also should be accordingly. It should be vatashamaka, agnisamyakaraand medoshoshaka. The treatment isopposite in nature and is very difficult to treat. So,today there is a need to find the drug which is cost effective, easilyavailable and easy to follow.
One such preparation might be Sthaulyapakarshaniyakwatha which has few ingredients that are easily available. It has beenmentioned in Charak Samhita. It has the properties like Aampachana, Medoshoshanaand Vata-kaphahar. Lekhanabasti which has been praised for its scraping action has also beenconsidered for this research. Their effect at individual as well as combined levelcan be observed in hope to put an end to obesity.Onthe light of above, present study has been selected.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Open Label
入排标准
- 年龄范围
- 20.00 Year(s) 至 50.00 Year(s)（—）
- 性别
- All
入选标准
- •Well diagnosed patients of sthaulya.
- •(Diagnosis will be made on the basis of assessment criteria as mentioned in classical texts.) Patients having BMI in range of 25 – 35 kg/m
- •Patients with hyperlipidemia and/or type 2 DM.
排除标准
- •Patients having BMI more than 35 kg/m
- •Patients of age below 20 or more than 50 years.
- •Patients having major systemic disorders or other illness which interfere with the present study.
- •Patients of sthaulya with its severe complications like cerebral vascular diseases, ischemic heart diseases etc.
- •Patients with depression or having any other mental or psychiatric disorder.
- •Cases with alcohol dependence/ misuse and drug abuse.
- •Obesity associated with endocrinopathies.
结局指标
主要结局
Mild improvement - 1 to 33% relief
时间窗: 2 months of assessment period during treatment with 1 month of follow up
Unchanged - 0%
时间窗: 2 months of assessment period during treatment with 1 month of follow up
Moderate improvement - 33 to 66% relief
时间窗: 2 months of assessment period during treatment with 1 month of follow up
Complete remission - 100% relief
时间窗: 2 months of assessment period during treatment with 1 month of follow up
Marked improvement - 66 to 99% relief
时间窗: 2 months of assessment period during treatment with 1 month of follow up
次要结局
- Exacerbation in sign and symptoms(2 months)